— Know what they know.
Not Investment Advice

SNDX NASDAQ

Syndax Pharmaceuticals, Inc.
1W: -3.8% 1M: -10.5% 3M: +0.4% YTD: -7.2% 1Y: +87.0% 3Y: -6.3% 5Y: +6.7%
$19.94
+0.17 (+0.86%)
 
Weekly Expected Move ±8.4%
$17 $19 $20 $22 $24
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 30 · $1.8B mcap · 79M float · 2.01% daily turnover · Short 60% of daily vol

📊 Key Metrics

TTM
$217M
Revenue
+396.7% YoY
$-243M
Net Income
+26.6% YoY
$-278M
Free Cash Flow
+2.9% YoY
95.9%
Gross Margin
-52.7%
Op. Margin
-65.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-137.9%
ROA-38.8%
ROIC-1036.1%

Valuation

P/E-7.1
P/B41.5
EV/EBITDA-11.8

Leverage

Debt/Equity5.36
Current Ratio4.40
Interest Cov.-2.2x

Quality Scores

Piotroski F3/9
Altman Z-1.08
Beneish M-0.72

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms